BrightSpring Health Services, Inc. Increase (Decrease) in Accounts Receivable
BrightSpring Health Services, Inc. (BTSG) reported Increase (Decrease) in Accounts Receivable of $152.58 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-07-31
- BrightSpring Health Services, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $38.45M, a 15.45% increase year-over-year.
- BrightSpring Health Services, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $114.13M, a 43.65% increase year-over-year.
- BrightSpring Health Services, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$31.40M, a 308.73% decline year-over-year.
- BrightSpring Health Services, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $49.93M, a 2.99% decline year-over-year.
- BrightSpring Health Services, Inc. increase (decrease) in accounts receivable for fiscal 2025 was $131.29M, a 26.67% decline from fiscal 2024.
- BrightSpring Health Services, Inc. increase (decrease) in accounts receivable for fiscal 2024 was $179.04M, a 40.70% increase from fiscal 2023.
- BrightSpring Health Services, Inc. increase (decrease) in accounts receivable for fiscal 2023 was $127.25M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $38.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $152.58M 10-Q · filed 2026-07-31 | $121.17M derived: sum of 3 quarters · filed 2026-07-31 | $171.11M derived: sum of 4 quarters · filed 2026-07-31 |
| 2026-03-31 | $114.13M 10-Q · filed 2026-05-01 | $82.72M derived: sum of 2 quarters · filed 2026-05-01 | $132.66M derived: sum of 3 quarters · filed 2026-05-01 | $165.96M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-12-31 | -$31.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $18.53M derived: sum of 2 quarters · filed 2026-02-27 | $51.84M derived: sum of 3 quarters · filed 2026-07-31 | $131.29M 10-K · filed 2026-02-27 |
| 2025-09-30 | $49.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $83.24M derived: sum of 2 quarters · filed 2026-07-31 | $162.69M 10-Q · filed 2025-10-28 | $177.73M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-06-30 | $33.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $112.76M 10-Q · filed 2026-07-31 | $127.80M derived: sum of 3 quarters · filed 2026-07-31 | $179.27M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-03-31 | $79.45M 10-Q · filed 2026-05-01 | $94.49M derived: sum of 2 quarters · filed 2026-05-01 | $145.97M derived: sum of 3 quarters · filed 2026-05-01 | $142.91M derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | $15.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $66.52M derived: sum of 2 quarters · filed 2026-02-27 | $63.46M derived: sum of 3 quarters · filed 2026-02-27 | $179.04M 10-K · filed 2026-02-27 |
| 2024-09-30 | $51.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $48.42M derived: sum of 2 quarters · filed 2025-10-28 | $164.00M 10-Q · filed 2025-10-28 | $174.32M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | -$3.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $112.52M 10-Q · filed 2025-08-01 | $122.85M derived: sum of 3 quarters · filed 2026-02-27 | $134.37M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $115.58M 10-Q · filed 2025-05-02 | $125.90M derived: sum of 2 quarters · filed 2026-02-27 | $137.42M derived: sum of 3 quarters · filed 2026-02-27 | $188.79M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $10.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $21.84M derived: sum of 2 quarters · filed 2026-02-27 | $73.21M derived: sum of 3 quarters · filed 2026-02-27 | $127.25M 10-K · filed 2026-02-27 |
| 2023-09-30 | $11.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $62.89M derived: sum of 2 quarters · filed 2024-11-01 | $116.92M 10-Q · filed 2024-11-01 | |
| 2023-06-30 | $51.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $105.40M 10-Q · filed 2024-08-02 | ||
| 2023-03-31 | $54.03M 10-Q · filed 2024-05-02 | |||
| 2022-12-31 | $150.47M 8-K · filed 2025-06-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHEMED CORP (CHE) | United States | $6.474B | 22.14 |
| Option Care Health, Inc. (OPCH) | United States | $3.602B | 20.52 |
| Aveanna Healthcare Holdings, Inc. (AVAH) | United States | $2.703B | 7.22 |
| Addus HomeCare Corp (ADUS) | United States | $2.129B | 17.80 |
| AdaptHealth Corp. (AHCO) | United States | $0.759B | -6.22 |